The Role of Ganoderma lucidum Uptake on Some Hematological and Immunological Response in Patients with Coronavirus (COVID-19) (2020)


Sys Rev Pharm 2020;11(8):537-541


At the end of 2019, the novel coronavirus was discovered to cause pneumonia in Wuhan city in the Hubei Province, China. Later it has caused significant worldwide crises due to its fast transmission between humans, causing a widespread pandemic around the world. 150 patients with COVID19 were collected from Shirqat hospital, their ages were between 35-55 years. The patients were divided into four groups. as follows: (1) The healthy control group: normal apparently healthy individuals, (2) G. lucidum group: Healthy individuals received G. lucidum orally, (3) COVID-19 Patients: patients infected with COVID-19, (4) Human convalescent plasma: this group treated Human convalescent plasma for intravenous injection, and (5) Patients COVID-19+ G. lucidum group: this group after infection and treated with G. lucidum, (6) COVID-19 Patients + Human convalescent plasma: this group treated with Human convalescent plasma for intravenous injection. The immunoglobulin (IgG and IgM) were positive in Patients with the COVID19 group, whereas (IgG) only was positive in Patients COVID-19+G.lucidum and Patients COVID-19+ Human convalescent. The IgM was negative in Patients with COVID-19+G.lucidum and Patients with COVID-19+ Human convalescent groups. The result found that there was a significant change between the study groups (p<0.05) in total white blood cells, there was a less significant increase in G. lucidum group compared with control group. The lymphocyte was significantly decrease for patients with COVID-19 group compared with control group, while significant increase were seen in G. lucidum group and Human convalescent plasma compared with control group and the patients with COVID-19 + G.lucidum group results showed a significant increase compared with patients COVID-19 group.The result showed a significant decrease (p<0.05) in Patients with COVID-19 group of Hb, PCV, RBCs, and Platelet compared with the control group and G.lucidum group, while there was no significant change in the G.lucidum group and Human convalescent plasma group compared with the control group. Convalescent plasma together with the hyperimmune immunoglobulin have appositive effects on treating the COVID-19, as well as the G. lucidum has a great significant role in reducing the COVID-19 malicious effect on the studied hematological parameters. G. lucidum can be used to help in the treatment of COVID-19 infections.


Related articles

Medicated mushrooms are mushrooms used as medicine. They have been used for hundreds of years to treat infections, especially in Asia. Today medicinal mushrooms are also used to treat lung disease and cancer.

Eating L. edodes for 4 weeks resulted in increased ex vivo proliferation of γδ-T (60% more, p < 0.0001) and NK-T (2-fold more, p < 0.0001) cells. Both cell types also demonstrated a greater ability to express activation receptors, suggesting that consuming mushrooms improved cell effector function.

Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths, and over 60% of patients present with advanced stages.

To evaluate the efficacy of Krestin (PSK) as adjuvant treatment after radical radiation therapy (RT) for non-small cell lung cancer (NSCLC), treatment results of 225 patients with NSCLC treated with RT followed by adjuvant administration of PSK between 1976 and 1989 were analyzed. Of these patients, 170 (76%) had squamous cell carcinoma.


Top Quality Mushroom

© 2023 Biosan Biotech Co.,Ltd. All Rights Reserved. Powered

We use optional cookies to improve your experience on our website, including through social media connections and to serve personalized advertising based on your online activity. If you reject optional cookies, we will only use cookies that are necessary to provide you with the service.